Nkarta reports second quarter 2023 financial results and corporate highlights

South san francisco, calif., aug. 10, 2023 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a clinical-stage biopharmaceutical company developing engineered natural killer (nk) cell therapies, today reported financial results for the second quarter ended june 30, 2023.
NKTX Ratings Summary
NKTX Quant Ranking